These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1957291)

  • 1. [Substance abuse analysis of biological materials].
    Christophersen AS; Mørland J
    Tidsskr Nor Laegeforen; 1991 Nov; 111(27):3300-3. PubMed ID: 1957291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [On-site testing for drug abuse in urine].
    Espnes KA; Spigset O; Delaveris GJ; Mørland J; Smith-Kielland A
    Tidsskr Nor Laegeforen; 2006 Sep; 126(17):2257-60. PubMed ID: 16967064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine testing in the detection of drugs of abuse.
    Schwartz RH
    Arch Intern Med; 1988 Nov; 148(11):2407-12. PubMed ID: 3056313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Legal issues in oral fluid testing.
    Kadehjian L
    Forensic Sci Int; 2005 Jun; 150(2-3):151-60. PubMed ID: 15944055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatic screening in postmortem toxicology.
    Stimpfl T; Vycudilik W
    Forensic Sci Int; 2004 Jun; 142(2-3):115-25. PubMed ID: 15172075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Forensic analysis of carbohydrate-deficient transferrin (CDT): implementation of a screening and confirmatory analysis concept is hampered by the lack of CDT isoform standards.
    Arndt T; Keller T
    Forensic Sci Int; 2004 Nov; 146(1):9-16. PubMed ID: 15485716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-testing methods and clinical interpretations of test results.
    Kapur BM
    Bull Narc; 1993; 45(2):115-54. PubMed ID: 7920539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three commercial tests for buprenorphine screening in urine.
    Leino A; Loo BM
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):563-5. PubMed ID: 17961313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical dependency and drug testing in the workplace.
    Osterloh JD; Becker CE
    West J Med; 1990 May; 152(5):506-13. PubMed ID: 2190418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for urinary amphetamine in truck drivers and drug addicts.
    Pidetcha P; Congpuong P; Putriprawan T; Rekakanakul R; Suwanton L; Tantrarongroj S
    J Med Assoc Thai; 1995 Oct; 78(10):554-8. PubMed ID: 8576663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-site testing of illicit drugs: the use of the drug-testing device "Toxiquick".
    Biermann T; Schwarze B; Zedler B; Betz P
    Forensic Sci Int; 2004 Jun; 143(1):21-5. PubMed ID: 15177627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Four years' experience in external proficiency testing programs for hair testing of drugs of abuse in Italy (HAIRVEQ) and comparison with the Society of Hair Testing program in 2005.
    Ventura M; Pichini S; Pujadas M; Ventura R; Di Giovannandrea R; Zuccaro P; Pacifici R; Langohr K; Jurado C; de la Torre R
    Ther Drug Monit; 2007 Feb; 29(1):11-9. PubMed ID: 17304145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of random drug testing in an adolescent substance abuse program.
    Levy S; Sherritt L; Vaughan BL; Germak M; Knight JR
    Pediatrics; 2007 Apr; 119(4):e843-8. PubMed ID: 17403828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug addiction in the medico-legal certification of the Department of Forensic Medicine of Medical University of Gdańsk in the years 1996-2005].
    Galer-Tatarowicz K; Wiergowski M; Szpiech B; Reguła K; Jankowski Z
    Arch Med Sadowej Kryminol; 2007; 57(3):277-84. PubMed ID: 17907619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants.
    Boumba VA; Ziavrou KS; Vougiouklakis T
    Int J Toxicol; 2006; 25(3):143-63. PubMed ID: 16717031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of hair analysis in postmortem toxicology.
    Kintz P
    Forensic Sci Int; 2004 Jun; 142(2-3):127-34. PubMed ID: 15172076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug screening in clinical or forensic toxicology: are there differences?
    Gerostamoulos D; Beyer J
    J Law Med; 2010 Sep; 18(1):25-8. PubMed ID: 20977157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal issues of addiction assessment: the experience with hair testing in Greece.
    Savvopoulos MA; Pallis E; Tzatzarakis MN; Dialyna IA; Tzanakakis GN; Tsatsakis AM
    J Appl Toxicol; 2005; 25(2):143-52. PubMed ID: 15744757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forensic application of testing hair for drugs of abuse.
    Miller ML; Donnelly B; Martz RM
    NIDA Res Monogr; 1997; 167():146-60. PubMed ID: 9243561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.